SERA PROGNOSTICS, INC. Operating Expenses
SERA PROGNOSTICS, INC. (SERA) reported Operating Expenses of $10.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-12
- SERA PROGNOSTICS, INC. operating expenses for the quarter ending 2026-06-30 was $10.03M, a 7.46% increase year-over-year.
- SERA PROGNOSTICS, INC. operating expenses for the quarter ending 2026-03-31 was $9.37M, a 0.93% increase year-over-year.
- SERA PROGNOSTICS, INC. operating expenses for the quarter ending 2025-12-31 was $8.96M, a 5.11% decline year-over-year.
- SERA PROGNOSTICS, INC. operating expenses for the quarter ending 2025-09-30 was $9.00M, a 1.18% increase year-over-year.
- SERA PROGNOSTICS, INC. operating expenses for fiscal 2025 was $36.59M, a 0.35% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. operating expenses for fiscal 2024 was $36.71M, a 8.51% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. operating expenses for fiscal 2023 was $40.13M, a 12.62% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. operating expenses for fiscal 2022 was $45.92M, a 29.44% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.03M 10-Q · filed 2026-08-12 | $19.41M 10-Q · filed 2026-08-12 | $28.37M derived: sum of 3 quarters · filed 2026-08-12 | $37.37M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $9.37M 10-Q · filed 2026-05-06 | $18.34M derived: sum of 2 quarters · filed 2026-05-06 | $27.33M derived: sum of 3 quarters · filed 2026-05-06 | $36.67M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $17.96M derived: sum of 2 quarters · filed 2026-03-18 | $27.30M derived: sum of 3 quarters · filed 2026-08-12 | $36.59M 10-K · filed 2026-03-18 |
| 2025-09-30 | $9.00M 10-Q · filed 2025-11-13 | $18.33M derived: sum of 2 quarters · filed 2026-08-12 | $27.62M 10-Q · filed 2025-11-13 | $37.07M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $9.34M 10-Q · filed 2026-08-12 | $18.63M 10-Q · filed 2026-08-12 | $28.07M derived: sum of 3 quarters · filed 2026-08-12 | $36.96M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $9.29M 10-Q · filed 2026-05-06 | $18.73M derived: sum of 2 quarters · filed 2026-05-06 | $27.63M derived: sum of 3 quarters · filed 2026-05-06 | $36.90M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $18.34M derived: sum of 2 quarters · filed 2026-03-18 | $27.61M derived: sum of 3 quarters · filed 2026-03-18 | $36.71M 10-K · filed 2026-03-18 |
| 2024-09-30 | $8.89M 10-Q · filed 2025-11-13 | $18.17M derived: sum of 2 quarters · filed 2025-11-13 | $27.27M 10-Q · filed 2025-11-13 | $36.15M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $9.28M 10-Q · filed 2025-08-06 | $18.37M 10-Q · filed 2025-08-06 | $27.26M derived: sum of 3 quarters · filed 2025-08-06 | $35.49M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $9.10M 10-Q · filed 2025-05-07 | $17.99M derived: sum of 2 quarters · filed 2025-05-07 | $26.21M derived: sum of 3 quarters · filed 2025-05-07 | $37.80M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $17.11M derived: sum of 2 quarters · filed 2025-03-19 | $28.70M derived: sum of 3 quarters · filed 2025-03-19 | $40.13M 10-K · filed 2025-03-19 |
| 2023-09-30 | $8.23M 10-Q · filed 2024-11-06 | $19.81M derived: sum of 2 quarters · filed 2024-11-06 | $31.24M 10-Q · filed 2024-11-06 | $41.72M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $11.58M 10-Q · filed 2024-08-07 | $23.01M 10-Q · filed 2024-08-07 | $33.49M derived: sum of 3 quarters · filed 2024-08-07 | $44.77M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $11.43M 10-Q · filed 2024-05-08 | $21.91M derived: sum of 2 quarters · filed 2024-05-08 | $33.19M derived: sum of 3 quarters · filed 2024-05-08 | $45.01M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $10.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $21.76M derived: sum of 2 quarters · filed 2024-03-20 | $33.58M derived: sum of 3 quarters · filed 2024-03-20 | $45.92M 10-K · filed 2024-03-20 |
| 2022-09-30 | $11.28M 10-Q · filed 2023-11-08 | $23.10M derived: sum of 2 quarters · filed 2023-11-08 | $35.44M 10-Q · filed 2023-11-08 | $48.01M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $11.82M 10-Q · filed 2023-08-09 | $24.16M 10-Q · filed 2023-08-09 | $36.73M derived: sum of 3 quarters · filed 2023-08-09 | $46.20M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $12.34M 10-Q · filed 2023-05-10 | $24.91M derived: sum of 2 quarters · filed 2023-05-10 | $34.38M derived: sum of 3 quarters · filed 2023-05-10 | $41.78M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $12.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $22.04M derived: sum of 2 quarters · filed 2023-03-22 | $29.44M derived: sum of 3 quarters · filed 2023-03-22 | $35.48M 10-K · filed 2023-03-22 |
| 2021-09-30 | $9.46M 10-Q · filed 2022-11-09 | $16.87M derived: sum of 2 quarters · filed 2022-11-09 | $22.90M 10-Q · filed 2022-11-09 | $27.66M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $7.40M 10-Q · filed 2022-08-10 | $13.44M 10-Q · filed 2022-08-10 | $18.20M derived: sum of 3 quarters · filed 2022-08-10 | $22.85M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $6.04M 10-Q · filed 2022-05-10 | $10.80M derived: sum of 2 quarters · filed 2022-05-10 | $15.45M derived: sum of 3 quarters · filed 2022-05-10 | $19.73M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $9.41M derived: sum of 2 quarters · filed 2022-03-29 | $13.70M derived: sum of 3 quarters · filed 2022-03-29 | $18.00M 10-K · filed 2022-03-29 |
| 2020-09-30 | $4.65M 10-Q · filed 2021-11-09 | $8.94M derived: sum of 2 quarters · filed 2021-11-09 | $13.24M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $4.29M 10-Q · filed 2021-08-30 | $8.59M 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |